1H, 13C and 15N backbone resonance assignment of the catalytic domain of human PTPN22

被引:0
作者
Martin, Bryan T. [1 ]
Clarkson, Michael W. [1 ]
Wu, Ping [1 ]
Di Lello, Paola [1 ]
机构
[1] Genentech Inc, Dept Struct Biol Prot Sci, South San Francisco, CA 94080 USA
关键词
PTPN22; Phosphatases; NMR assignment; Drug discovery; NMR spectroscopy; LYMPHOID TYROSINE PHOSPHATASE; LYP; IDENTIFICATION; INHIBITOR;
D O I
10.1007/s12104-025-10233-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Protein Tyrosine Phosphatase Non-receptor type 22 (PTPN22) is a tyrosine-phosphatase that plays a major role in inhibiting T-cell activation in immune cells. Recent studies have revealed that downregulation of PTPN22 triggers T-cell activation and enhances antitumor immune response, thereby identifying PTPN22 as a potential pharmacological target in cancer-immunology.Here we report the 1H, 15N and 13C backbone resonance assignment for the 35.6 kDa catalytic domain of human PTPN22. This assignment will provide an essential experimental tool to identify and characterize potential PTPN22 inhibitors.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 22 条
  • [1] A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis
    Begovich, AB
    Carlton, VEH
    Honigberg, LA
    Schrodi, SJ
    Chokkalingam, AP
    Alexander, HC
    Ardlie, KG
    Huang, QQ
    Smith, AM
    Spoerke, JM
    Conn, MT
    Chang, M
    Chang, SYP
    Saiki, RK
    Catanese, JJ
    Leong, DU
    Garcia, VE
    McAllister, LB
    Jeffery, DA
    Lee, AT
    Batliwalla, F
    Remmers, E
    Criswell, LA
    Seldin, MF
    Kastner, DL
    Amos, CI
    Sninsky, JJ
    Gregersen, PK
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (02) : 330 - 337
  • [2] Deletion of PTPN22 improves effector and memory CD8+ T cell responses to tumors
    Brownlie, Rebecca J.
    Wright, David
    Zamoyska, Rose
    Salmond, Robert J.
    [J]. JCI INSIGHT, 2019, 4 (16)
  • [3] Resistance to TGFβ suppression and improved anti-tumor responses in CD8+ T cells lacking PTPN22
    Brownlie, Rebecca J.
    Garcia, Celine
    Ravasz, Mate
    Zehn, Dietmar
    Salmond, Robert J.
    Zamoyska, Rose
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [4] Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp
    Cohen, S
    Dadi, H
    Shaoul, E
    Sharfe, N
    Roifman, CM
    [J]. BLOOD, 1999, 93 (06) : 2013 - 2024
  • [5] Autoimmunity linked protein phosphatase PTPN22 as a target for cancer immunotherapy
    Cubas, Rafael
    Khan, Zia
    Gong, Qian
    Moskalenko, Marina
    Xiong, Huizhong
    Ou, Qinglin
    Pai, Christine
    Rodriguez, Ryan
    Cheung, Jeanne
    Chan, Andrew C.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [6] NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES
    DELAGLIO, F
    GRZESIEK, S
    VUISTER, GW
    ZHU, G
    PFEIFER, J
    BAX, A
    [J]. JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) : 277 - 293
  • [7] Autoimmune-associated PTPN22 R620W Variation Reduces Phosphorylation of Lymphoid Phosphatase on an Inhibitory Tyrosine Residue
    Fiorillo, Edoardo
    Orru, Valeria
    Stanford, Stephanie M.
    Liu, Yingge
    Salek, Mogjiborahman
    Rapini, Novella
    Schenone, Aaron D.
    Saccucci, Patrizia
    Delogu, Lucia G.
    Angelini, Federica
    Bitti, Maria Luisa Manca
    Schmedt, Christian
    Chan, Andrew C.
    Acuto, Oreste
    Bottini, Nunzio
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (34) : 26506 - 26518
  • [8] Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO
  • [9] 2-U
  • [10] A Potent and Selective Small-Molecule Inhibitor for the Lymphoid-Specific Tyrosine Phosphatase (LYP), a Target Associated with Autoimmune Diseases
    He, Yantao
    Liu, Sijiu
    Menon, Ambili
    Stanford, Stephanie
    Oppong, Emmanuel
    Gunawan, Andrea M.
    Wu, Li
    Wu, Dennis J.
    Barrios, Amy M.
    Bottini, Nunzio
    Cato, Andrew C. B.
    Zhang, Zhong-Yin
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (12) : 4990 - 5008